SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 110 filers reported holding SUTRO BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is 1.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $376,823 | -40.8% | 108,595 | -20.6% | 0.00% | 0.0% |
Q2 2023 | $636,127 | -1.5% | 136,802 | -2.2% | 0.00% | 0.0% |
Q1 2023 | $646,009 | -26.6% | 139,829 | +28.3% | 0.00% | -50.0% |
Q4 2022 | $880,419 | +45.8% | 108,963 | -0.3% | 0.00% | +100.0% |
Q3 2022 | $604,000 | -10.9% | 109,255 | -16.3% | 0.00% | 0.0% |
Q2 2022 | $678,000 | +65.4% | 130,464 | +160.0% | 0.00% | 0.0% |
Q1 2022 | $410,000 | +58.9% | 50,176 | +188.9% | 0.00% | – |
Q4 2021 | $258,000 | -21.3% | 17,369 | 0.0% | 0.00% | -100.0% |
Q3 2021 | $328,000 | +1.9% | 17,369 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $322,000 | -74.5% | 17,369 | -68.7% | 0.00% | -50.0% |
Q1 2021 | $1,263,000 | +13.8% | 55,534 | +8.4% | 0.00% | 0.0% |
Q4 2020 | $1,110,000 | +299.3% | 51,225 | +83.7% | 0.00% | +100.0% |
Q3 2020 | $278,000 | +231.0% | 27,886 | +155.2% | 0.00% | – |
Q2 2020 | $84,000 | -25.7% | 10,925 | -2.6% | 0.00% | – |
Q1 2020 | $113,000 | -4.2% | 11,216 | +3.3% | 0.00% | – |
Q4 2019 | $118,000 | – | 10,857 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SV Health Investors, LLC | 1,824,542 | $39,611,000 | 19.08% |
Samsara BioCapital, LLC | 1,675,579 | $36,377,000 | 3.66% |
SILVERARC CAPITAL MANAGEMENT, LLC | 185,000 | $4,016,000 | 2.33% |
Affinity Asset Advisors, LLC | 200,000 | $4,342,000 | 2.30% |
Altium Capital Management LP | 276,719 | $6,008,000 | 2.24% |
FRAZIER MANAGEMENT LLC | 1,001,421 | $21,741,000 | 1.67% |
BVF INC/IL | 1,854,162 | $40,254,000 | 1.58% |
Asymmetry Capital Management, L.P. | 157,583 | $3,421,000 | 1.56% |
Parkman Healthcare Partners LLC | 266,645 | $5,789,000 | 1.48% |
AJU IB Investment Co., Ltd. | 175,000 | $3,799,000 | 1.44% |